Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
The standard of care for pancreatic cancer has remained largely unchanged for the past two decades, but now scientists have identified 10 different genetic pathways driving the disease,…
The intersection of wearable health-monitoring devices and telemedicine platforms might lead to better management of chronic diseases like diabetes, hypertension, and obesity. As patients gain access to improved…
Almost 10% of the US population is afflicted with diabetes, and a much greater percentage is at risk of developing diabetes as they age. Researchers have been busy…
Patients with type-2 diabetes have an FDA-approved medication option that will help reduce blood sugar levels in conjunction with diet and exercise. Sodium-glucose Cotransporter-2 (SGLT2) inhibitors, including canagliflozin,…
Insulin resistance is a major precursor to the development of type-2 diabetes. Obesity is the primary cause of insulin resistance in both male and female patients, but a…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
